SBIR/STTR Research Award
COMMERCIAL PROTOTYPE OF OPTOACOUSTIC BREAST IMAGER
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LASERSONIX TECHNOLOGIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Verbatim from the Applicant's Abstract): Experimental work done to
date indicates that Opto-Acoustic Tomography will provide breast images with
greater contrast and sensitivity to cancer than the currently preferred
methods. In a Laser Optoacoustic Imaging System (LOIS) short near-infrared
laser pulses are absorbed preferentially in tumors to generate pressure
profiles resembling distribution of absorbed optical energy in the breast.
Variation of the laser wavelength permits targeting either blood-rich malignant
carcinoma or fibrous-tissue-rich fibroadenoma. Therefore, pressure waves
emanating from tumors deliver information to the breast surface not only about
the location and dimensions of tumors, but also diagnostic information. At the
breast surface signals are detected by wide-band, piezoelectric transducers and
analyzed to generate an image. Extensive laboratory research has proven the
practicality and significant advantages of LOIS. LOIS is suitable for
examination of all breasts independently on skin color, age and radiological
density. The goal of the work proposed is to develop a commercial prototype
instrument. The work during the Phase I project will focus on the general
design, design of system components and fabrication of an advanced
opto-acoustic array detector. Fabricated system components will be employed in
the clinical research system at UTMB and tested with five breast cancer
patients.
PROPOSED COMMERCIAL APPLICATION:
The proposed work will ultimately lead to a commercial device that will be useful as a primary
tool in screening for breast cancer and as a secondary imaging tool for reduction of the large
number of false positives generated by other screening procedures, such as X-ray mammography. The estimated cost per examination will be comparable to that for an
ultrasonic image. The device will be suitable for guiding needle biopsies of suspicious
lesions and new thermal therapeutic methods (such as focused ultrasound or laser,
fiber-optic ablation) for eradication of those lesions. A potential for eventual application of
the equipment in various diagnostic, monitoring and therapeutic procedures will guide further
design considerations.
Technology keywords
Not reported